Betahistine Tablets IP 8Mg – LECTIL 8 Tablets

LECTIL 8 Tablets
Composition:- Betahistine 8mg

LECTIL 8 Tablets contains Betahistine Tablets IP 8mg, a histamine analogue that acts as a partial agonist at H1 receptors and a potent antagonist at H3 receptors in the inner ear. It improves microvascular circulation in the stria vascularis of the cochlea and reduces endolymphatic pressure, making it effective in the management of vestibular disorders.

Marketed by: Wonne International Pvt. Ltd.

Key points of Betahistine Tablets IP 8Mg – LECTIL 8 Tablets

• Dual receptor action  — partial H1 agonist and strong H3 antagonist, increasing histamine turnover in vestibular nuclei to restore balance signalling.
• Improves cochlear microcirculation  — enhances blood flow to the inner ear, reducing endolymphatic hydrops and pressure.
• Effective in Ménière’s disease  — reduces frequency and severity of vertigo attacks, tinnitus, and hearing fluctuation.
• Flexible dosing  — usual dose 8–16 mg three times daily with food; titrated up to 48 mg/day based on response
• Good tolerability profile  — generally well tolerated; GI side effects (nausea, dyspepsia) minimised when taken with meals

Can be Prescribed by:

• ENT / Otolaryngology
• Neurology
• General Practice
• Geriatrics
• Internal Medicine

Disclaimer: To be used under medical supervision only and not intended for general public promotion. This content is meant for registered healthcare professionals only.